Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/CYCLACEL-PHARMACEUTICALS--11337534/news/First-Patient-Dosed-in-IST-of-CDK-Inhibitor-Seliciclib-in-Cushing-s-Disease-a-Serious-Endocrine-Dis-20632249/?utm_source=whatsapp&utm_medium=social&utm_campaign=share